Transcriptional inhibition of CYP24 by genistein

Annals of the New York Academy of Sciences

Volumn 973, Issue , 2002, Pages 459-462

  Farhan, Hesso ^a   Cross, Heide S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Histone deacetylase inhibition; Isoflavonoids; Prostate cancer therapy; Vitamin D metabolism

Indexed keywords

CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24; GENISTEIN; HISTONE DEACETYLASE; MESSENGER RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG; VITAMIN D;

CANCER CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS;

EID: 0036962031     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04683.x     Document Type: Conference Paper

References (2)

1. MILLER, G.J., G.E. STAPLETON, T.E. HEDLUND & K.A. MOFFAT. 1995. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin. Cancer Res. 1: 997-1003
2. MARKS, P.A., V.M. RICHON, R. BRESLOW & R.A. RIFKIND. 2001. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13: 477-483.